Kestra Medical Technologies CEO Brian Webster sells $692,214 in stock
Kestra Medical Technologies' CEO Brian Webster divested $692,214 worth of company shares in three separate transactions between July 30 and August 3, 2026. The sales occurred at prices between $22.6039 and $23.9244 per share, with Webster owning 527,115 common shares post-transaction. The stock has since risen to $28.02, nearing its 52-week high of $30.00 following a 75% gain over the past year. Analysts consider the stock overvalued relative to its Fair Value, making it a candidate for inclusion on overvalued lists.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
